Patient-Focused Business Solutions
for Biopharmaceutical and
Healthcare Industry
Patient-Focused Business Solutions
for Biopharmaceutical and
Healthcare Industry
Why patient experience is important
Patient Experience
Adds to a full understanding of program strengths and risks
Increase likelihood of success
Evaluating how treatments impact patient experiences, such as signs, symptoms, physical functioning, and limitations in daily activities, is critical for a full assessment of medical product effectiveness and safety
Increase likelihood of success
Adds to a full understanding of program strengths and risks
Increase likelihood of success
Demonstrating a benefit on the patient’s experience can substantially increase the likelihood of global regulatory and commercial success
Adds to a full understanding of program strengths and risks
Adds to a full understanding of program strengths and risks
Adds to a full understanding of program strengths and risks
Private Equity and Investment Firms: Biotechnology and pharmaceutical investors needs evaluation of all aspects of a development program to understand the strengths and risks associated with a new product. This includes an evaluation of how patient experiences are incorporated in clinical trials
Our Framework
Understanding the patient’s experience – of their condition and its treatment – is essential in medical product development and clinical care
Mission
Our mission is to support innovation, growth, and improved outcomes in the biopharmaceutical, medical technology, and healthcare industry through a focus on the patient’s experience. Consergo blends scientific, regulatory, and corporate expertise to deliver effective patient-focused business solutions to our clients.
Approach
Consergo leverages our industry experts to advise biopharmaceutical and healthcare companies on how to understand, drive, and improve the patient experience in the context of meeting critical business imperatives
Consergo Services
In-licensing Services
Strategic Support Services
Out-licensing Services
One of the Pharma industry's core tensions is reconciling a scientific mindset with the demands of a commercial environment.
We can support private equity and biopharma company investors in identifying the strengths and limitations of their patient experience strategy.
Out-licensing Services
Strategic Support Services
Out-licensing Services
Support smaller companies to optimize their patient experience strategy when preparing for partnership with larger company or discussions with investors; outline the regulatory and commercial considerations to take a product to market.
Strategic Support Services
Strategic Support Services
Strategic Support Services
Strategic communication and Meeting Support with regulators and other healthcare stakeholders.
Senior advisory assistance with:
Advisory committee meeting, Scientific advice, EOP2, among others.
Regulatory Innovation Support: ISTAND, CPIM, EMA ITF, and more.
Advisory Board
Katarina Halling, BSC
Katarina Halling, BSC
Katarina Halling, BSC
Katarina Halling is an experienced leader in patient experience innovation and evidence generation. Formerly Executive Director at AstraZeneca, she built and led theglobal Patient Centered Science team, embedding patient insights and patient centered strategies into drug development across multiple therapy areas with a broad remit from e
Katarina Halling is an experienced leader in patient experience innovation and evidence generation. Formerly Executive Director at AstraZeneca, she built and led theglobal Patient Centered Science team, embedding patient insights and patient centered strategies into drug development across multiple therapy areas with a broad remit from early disease area strategy to delivery of patient centered medicines and solutions into markets. She is passionate about ensuring patient experience shapes strategy, science and impact.
Her experience includes leading the first PRO-CTCAE pilot as part of the FDA Project Patient Voice, and the building of Evidence Powerhouse to ensure that patient experience isa critical component of global-local collaborations.
Chad Gwaltney, Ph.D
Katarina Halling, BSC
Katarina Halling, BSC
Chad Gwaltney has spent the last 25 years developing innovative methods to capture patient-centered outcomes in clinical trials. He has published over 100 peer-reviewed articles, including industry best-practice guidelines on the use of patient-reported outcomes in medical product development, and has served as Principal Investigator on
Chad Gwaltney has spent the last 25 years developing innovative methods to capture patient-centered outcomes in clinical trials. He has published over 100 peer-reviewed articles, including industry best-practice guidelines on the use of patient-reported outcomes in medical product development, and has served as Principal Investigator on multiple US National Institutes of Health research grants.
In addition to his independent consulting experience, he has served as head of the Patient Experience division in the Hematology and Oncology franchise at Celgene and as Chief Scientist and Regulatory Advisor at eResearchTechnology.
Jean Paty, Ph.D
Katarina Halling, BSC
Jean Paty, Ph.D
Jean Paty has decades of experience both as a scientific and academic leader in the patient experience area, andas a seasoned business leader within the biopharmaceutical space. Jean has provided top biopharma companies with scientific advice on how to utilize data to maximize impact on stakeholders in the regulatory and medical/scientif
Jean Paty has decades of experience both as a scientific and academic leader in the patient experience area, andas a seasoned business leader within the biopharmaceutical space. Jean has provided top biopharma companies with scientific advice on how to utilize data to maximize impact on stakeholders in the regulatory and medical/scientific community. He has immense experience on analysis, interpretation, and dissemination of empirical findings. He has established leadership of strategic and scientific teams that leveraged patient experience data. Finally, he has served at the upper management level in biopharma for the last severalyears, integrating scientific expertise with critical business acumen. At Consergo, Jean serves as one of our Chief Scientific Advisors, providing key advice to Biopharma Leaders as it relates to the growing importance of patient experience.
Sean O'Quin
Katarina Halling, BSC
Jean Paty, Ph.D
Sean O’Quinn is a leading expert in patient-centered outcomes (PCO) and qualitative research. With a career spanning both industry and strategic consulting, Sean specializes in bridging the gap between clinical data and the lived patient experience to drive regulatory and commercial success.
Sean brings deep expertise in respiratory, immu
Sean O’Quinn is a leading expert in patient-centered outcomes (PCO) and qualitative research. With a career spanning both industry and strategic consulting, Sean specializes in bridging the gap between clinical data and the lived patient experience to drive regulatory and commercial success.
Sean brings deep expertise in respiratory, immunology, dermatology, and gastrointestinal diseases and is dedicated to advancing rigorous evidence-based qualitative methodologies. His work has been published in leading peer-reviewed journals, including The New England Journal of Medicine, the Journal of Patient-Reported Outcomes, Rheumatology, and the Journal of Asthma and Allergy.
Sean advises global pharmaceutical organizations on the development and validation of scientifically robust endpoints meaningful to patients – helping bring life-changing therapies to market.
Ralph R. Turner, PhD, MPH
Ralph R. Turner, PhD, MPH
Ralph R. Turner, PhD, MPH
Dr. Turner currently serves as a clinical outcomes consultant specializing in psychology, psychometrics, biostatistics, clinical trial design, and program evaluation.
Dr. Turner earned his M.A. and Ph.D. degrees in educational and developmental psychology from Syracuse University and his MPH in Quantitative Methods from the Harvard Schoo
Dr. Turner currently serves as a clinical outcomes consultant specializing in psychology, psychometrics, biostatistics, clinical trial design, and program evaluation.
Dr. Turner earned his M.A. and Ph.D. degrees in educational and developmental psychology from Syracuse University and his MPH in Quantitative Methods from the Harvard School of Public Health, Department of Biostatistics. Dr. Turner served on the psychology faculty at West Virginia University, directed the Rehabilitation Research and Development group at Abt Associates in Cambridge, MA, founded the Outcomes Research Group at Pfizer, and served as Vice President for Research at Phase V Technologies in Wellesley Hills, MA. He has authored over 50 papers in outcomes research spanning several disease areas, including oncology, cardiovascular, autoimmune, affective, and metabolic disorders.
Jonathan Curtis
Ralph R. Turner, PhD, MPH
Ralph R. Turner, PhD, MPH
Jonathan Curtis is an experienced business leader with over two decades of work across various fields and expertise areas. Jonathan has served as a general business consultant across several industries, including biopharma, legal, insurance, financial, and professional services. Jonathan has served in various roles across both startups a
Jonathan Curtis is an experienced business leader with over two decades of work across various fields and expertise areas. Jonathan has served as a general business consultant across several industries, including biopharma, legal, insurance, financial, and professional services. Jonathan has served in various roles across both startups and large corporate entities, including operations, finance, marketing, sales, subject-matter expertise, and strategy.
At Consergo, Jonathan is managing the company's market strategies, overseeing knowledge management, informing client management strategies, and serving as an overall business consultant, incorporating the company's patient experience focus into broader business initiatives.
John Tondra
Ralph R. Turner, PhD, MPH
John Tondra
John Tondra is an experienced operational manager who has worked with several startups and large multinational companies, both inside and outside the biopharma industry, overseeing development, technology transitions, and distribution silos.
John has served as the Vice President of Operations for Invivodata (now ERT), a consultant with
John Tondra is an experienced operational manager who has worked with several startups and large multinational companies, both inside and outside the biopharma industry, overseeing development, technology transitions, and distribution silos.
John has served as the Vice President of Operations for Invivodata (now ERT), a consultant with IQVIA, US Operations at Lofelt GmbH (now META), and currently serves as a founder and operations leader at Consergo.